Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations

doi:10.12998/wjcc.v11.i8.1753

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2524)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

127

WORD

HTML

1183

Figures (1-2)

306

Tables (1-2)

303

Sum=1957

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

153

Download

414

Sum=567

Mar 16, 2023 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Mar 16, 2023; 11(8): 1753-1760
Published online Mar 16, 2023. doi: 10.12998/wjcc.v11.i8.1753

Full Size Figure Download Figure

Figure 2 Kaplan-Meier survival analysis using mortality (as dependent variable) during first year of liver transplantation due to hepatocellular carcinoma and serum soluble FasL levels previously to liver transplantation lower/higher than 190 pg/mL (as independent variable). Both survival curves were compared by log rank and hazard ratio. sFasL: Soluble FasL.

Citation: Lorente L, Rodriguez ST, Sanz P, González-Rivero AF, Pérez-Cejas A, Padilla J, Díaz D, González A, Martín MM, Jiménez A, Cerro P, Portero J, Barrera MA. Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations . World J Clin Cases 2023; 11(8): 1753-1760
URL: https://www.wjgnet.com/2307-8960/full/v11/i8/1753.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i8.1753